EE322 A Cost Analysis for Macrovascular Events, Comparison of Glargine 300U/Ml (GLA-300) and Degludec 100U/Ml (IDeg-100) in the Treatment of Type 2 Diabetes Mellitus in Older Population or Renal Impairment Individuals in Latin America
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.588
https://www.valueinhealthjournal.com/article/S1098-3015(23)03718-X/fulltext
Title :
EE322 A Cost Analysis for Macrovascular Events, Comparison of Glargine 300U/Ml (GLA-300) and Degludec 100U/Ml (IDeg-100) in the Treatment of Type 2 Diabetes Mellitus in Older Population or Renal Impairment Individuals in Latin America
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03718-X&doi=10.1016/j.jval.2023.09.588
First page :
Section Title :
Open access? :
No
Section Order :
10081